Evidence map›Paper›PMID 33139735›Full record

ArticleNature communications2020

Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART.

Chenjie Wan, Nadine Bachmann, Venelin Mitov, François Blanquart, Susana Posada Céspedes, Teja Turk, Kathrin Neumann, Niko Beerenwinkel, Jasmina Bogojeska, Jacques Fellay and 15 more

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. HIV Reservoir: How to Measure It?Current HIV/AIDS reports · 2023
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Chenjie WanDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-4830-4604
Nadine BachmannDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-7303-9542
Venelin MitovDepartment of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland.ORCID 0000-0002-5227-5191
François BlanquartCenter for Interdisciplinary Research in Biology, Collège de France, Paris, France.
Susana Posada CéspedesSwiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0002-7459-8186
Teja TurkDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-3065-8578
Kathrin NeumannDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-5034-6999
Niko BeerenwinkelDepartment of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.ORCID 0000-0002-0573-6119
Jasmina BogojeskaIBM Research - Zurich, Zurich, Switzerland.
Jacques FellaySchool of Life Sciences, EPFL, Lausanne, Switzerland.ORCID 0000-0002-8240-939X
Volker RothDepartment of Mathematics and Computer Science, University of Basel, Basel, Switzerland.ORCID 0000-0003-0991-0273
Jürg BöniInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-7925-4852
Matthieu PerreauDivision of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Thomas KlimkaitMolecular Virology, Department Biomedicine - Petersplatz, University of Basel, Basel, Switzerland.ORCID 0000-0003-4945-6511
Sabine YerlyLaboratory of Virology, Geneva University Hospital, Geneva, Switzerland.ORCID 0000-0003-1668-696X
Manuel BattegayDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Laura WaltiDepartment of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Alexandra CalmyInstitute of Global Health, University of Geneva, Geneva, Switzerland.
Pietro VernazzaDivision of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland.
Enos BernasconiInfectious Diseases Service, Regional Hospital, Lugano, Switzerland.ORCID 0000-0002-9724-8373
Matthias CavassiniDivision of Infectious Diseases, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.
Karin J MetznerDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-4862-1503
Huldrych F GünthardDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-1142-6723
Roger D KouyosDepartment of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. Roger.Kouyos@usz.ch.ORCID 0000-0002-9220-8348
Swiss HIV Cohort Study

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The HIV-1 reservoir is the major hurdle to curing HIV-1. However, the impact of the viral genome on the HIV-1 reservoir, i.e. its heritability, remains unknown. We investigate the heritability of the HIV-1 reservoir size and its long-term decay by analyzing the distribution of those traits on viral phylogenies from both partial-pol and viral near full-length genome sequences. We use a unique nationwide cohort of 610 well-characterized HIV-1 subtype-B infected individuals on suppressive ART for a median of 5.4 years. We find that a moderate but significant fraction of the HIV-1 reservoir size 1.5 years after the initiation of ART is explained by genetic factors. At the same time, we find more tentative evidence for the heritability of the long-term HIV-1 reservoir decay. Our findings indicate that viral genetic factors contribute to the HIV-1 reservoir size and hence the infecting HIV-1 strain may affect individual patients' hurdle towards a cure.

Indexed as

AdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesCohort StudiesDNA, ViralFemaleGenome, ViralHIV-1HIV InfectionsHumansMaleTime FactorsViral LoadAnti-Retroviral AgentsDNA, Viral

Identifiers

PMID33139735
PMCPMC7608612

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.